Skip to main content
Watch Insiders
Market intelligence
TARSHealthcare

Tarsus Pharmaceuticals Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 15, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 15, 2026William J Phd LinkCorporate insiderSale12,500$78.38$979,745
Sep 4, 2026Elizabeth Yeu LinChief Medical OfficerSale13,953$87.50$1,220,885
Sep 4, 2026Bobak R. AzamianPresident/CEO and Board ChairSale10,000$90.56$905,600
🔒 Unlock Real-Time Alerts and 2 More High-Conviction Rows — Subscribe to Watch Insiders Premium